VRCA David Zawitz buys $0 worth of shares
Nov 26, 2025, 5:36 AM
0.00%
What does VRCA do
Verrica Pharmaceuticals, headquartered in West Chester, Pennsylvania, develops treatments for skin diseases and went public in June 2018. Its pipeline includes YCANTH, VP-315, and VP-103 for various skin conditions.
David Zawitz bought 12,500 shares of VRCA on 25 November at $0.00 per share, worth a total of $0. They now own 21,000 VRCA shares, or a 147% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.